EUVIMEDEUVIMED entdecken
Crossref

Human epidermal growth factor receptor 2(Her2)-targeted pH-responsive MR/NIRF bimodal imaging-mediated nano-delivery system for the diagnosis and treatment of undifferentiated thyroid cancer

Qiushi Jia, Fulin Li, Chunxiang Li, Changzhi Guo, Shuang Wu, Liguo Hao, Zhongyuan Li iD

Drug Delivery and Translational Research · 2025

DOI: 10.1007/s13346-024-01727-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Delivery and Translational Research, 2025. Verfasst von Qiushi Jia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Imaging, School of Medical Technology, Qiqihar Medical University, Qiqihar, 101006, China. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Erb-b2 Receptor Tyrosine Kinases, Sorafenib, Antineoplastic Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Natural Science Foundation of Heilongjiang Province, The Scientific Research Project of Heilongjiang Provincial Health and Wellness Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsErb-b2 Receptor Tyrosine KinasesSorafenibAntineoplastic AgentsHumansHydrogen-Ion ConcentrationAnimalsCell Line, TumorManganese CompoundsNanoparticlesAntibodies, Monoclonal, HumanizedIndocyanine GreenMagnetic Resonance ImagingOxidesSerum Albumin, HumanDrug Delivery SystemsDrug LiberationOptical ImagingMice, NudeMiceMice, Inbred BALB C

Stichwörter der Autor:innen

Diagnosis and treatment integrationMRI/NIRF bimodalityTargeted nano-delivery systemThyroid cancer

Substanzen

Manganese CompoundsErb-b2 Receptor Tyrosine KinasesAntibodies, Monoclonal, HumanizedSorafenibIndocyanine GreenOxidesSerum Albumin, HumanAntineoplastic AgentsERBB2 protein, humanmanganese dioxide

Autor:innen und Institutionen

  • Department of Molecular Imaging, School of Medical Technology, Qiqihar Medical University, Qiqihar, 101006, China.
  • Department of Molecular Imaging, The First Affiliated Hospital of Qiqihar Medical University, Qiqihar, 101006, China.
  • Department of Molecular Imaging, School of Medical Technology, Qiqihar Medical University, Qiqihar, 101006, China. haoliguo@qmu.edu.cn.
  • Department of Molecular Imaging, The First Affiliated Hospital of Qiqihar Medical University, Qiqihar, 101006, China. m15946506063@163.com.

ORCID-Profile: Zhongyuan Li

Förderung

  • Natural Science Foundation of Heilongjiang Province
  • The Scientific Research Project of Heilongjiang Provincial Health and Wellness Commission

Zitieren

APA

Jia, Q., Li, F., Li, C., Guo, C., Wu, S., Hao, L., & Li, Z. (2025). Human epidermal growth factor receptor 2(Her2)-targeted pH-responsive MR/NIRF bimodal imaging-mediated nano-delivery system for the diagnosis and treatment of undifferentiated thyroid cancer. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-024-01727-2

Vancouver

Jia Q, Li F, Li C, Guo C, Wu S, Hao L, et al. Human epidermal growth factor receptor 2(Her2)-targeted pH-responsive MR/NIRF bimodal imaging-mediated nano-delivery system for the diagnosis and treatment of undifferentiated thyroid cancer. Drug Delivery and Translational Research. 2025. doi:10.1007/s13346-024-01727-2

BibTeX
@article{Jia2025,
  author = {Jia, Qiushi and Li, Fulin and Li, Chunxiang and Guo, Changzhi and Wu, Shuang and Hao, Liguo and Li, Zhongyuan},
  title = {Human epidermal growth factor receptor 2(Her2)-targeted pH-responsive MR/NIRF bimodal imaging-mediated nano-delivery system for the diagnosis and treatment of undifferentiated thyroid cancer},
  journal = {Drug Delivery and Translational Research},
  year = {2025},
  doi = {10.1007/s13346-024-01727-2}
}
Kostenlos starten →